Search

everythinglearnresearchcommunity

for

Search:↓

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Finasteride reduces hair growth and is safe for women with excessive hair.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Essential-oils-cobalt improves goat growth and product quality.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.